Cargando…
Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study
The amyloid plaques are a key hallmark of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Amyloidogenesis is a complex long-lasting multiphase process starting with the formation of nuclei of amyloid peptides: a process assigned as a primary nucleation. Curcumin (CU)...
Autores principales: | Doytchinova, Irini, Atanasova, Mariyana, Salamanova, Evdokiya, Ivanov, Stefan, Dimitrov, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563689/ https://www.ncbi.nlm.nih.gov/pubmed/32942739 http://dx.doi.org/10.3390/biom10091323 |
Ejemplares similares
-
Effects of Curcumin and Ferulic Acid on the Folding of Amyloid-β Peptide
por: Salamanova, Evdokiya, et al.
Publicado: (2021) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
por: Mladenova, Kirilka, et al.
Publicado: (2021) -
Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
por: Ivanov, Stefan M., et al.
Publicado: (2020) -
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
por: Stavrakov, Georgi, et al.
Publicado: (2020) -
Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors
por: Atanasova, Mariyana, et al.
Publicado: (2022)